AVGO three-lens brief
Evidence-based stock research on AVGO. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +3.99% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved +3.99% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $533.42 — 55% above current (47 analysts).
- Earnings scheduled 2026-12-09.
AVGO closed at $345.22 (+3.99%) as of 2026-11-12. Market cap: $1.65T. P/E (trailing) 44.1. Price is below the 50-day MA and below the 200-day MA. Positives: moved +3.99% yesterday.; analyst mean target $533.42 — 55% above current (47 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $29.59B, net income $13.09B, free cash flow $30.60B. Watching for: 2026-12-09 earnings release (27 days out).
Why three lenses on AVGO, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AVGO across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AVGO" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AVGO brief"></iframe>